Insight

Latest California Healthline Stories

Was The Novel Coronavirus Really Sneaky In Its Spread To The U.S.? Experts Say No.

Public health professionals dismissed the president’s claims that the spread of the coronavirus, in particular, and the threat of a pandemic, in general, snuck up on us as being “simply astonishing” and “simply untrue.”

KHN’s ‘What The Health?’: The Affordable Care Act Turns 10

Next week is the 10th anniversary of the Affordable Care Act. Millions of Americans have benefited from the law, yet its future is in the hands of both the Supreme Court and voters in November. For this special episode of “What the Health?” host Julie Rovner interviews Kathleen Sebelius, who was Obama’s secretary of Health and Human Services when the law was passed. Then Rovner, Joanne Kenen of Politico and Mary Agnes Carey of Kaiser Health News discuss its history, impact and prospects for the future.

Sebelius, Looking Back At ACA, Says The Country’s Never ‘Seen This Kind Of Battle’

On KHN’s “What the Health? ” podcast, the former secretary of Health and Human Services says she continued to believe during the debate 10 years ago on the health law that it would eventually gain some Republican support. But that never happened.

Take A Deep Breath: Making Risk-Based Decisions In The Coronavirus Era

There’s an array of recommendations about how to adjust our lives to reduce the spread of the novel virus. All are motivated by the same guiding principle: The better the public does in these efforts, the better off everyone will be.

Is The Bay Area’s ‘Unprecedented’ Lockdown The First Of Many?

About 7 million people across the San Francisco Bay Area began to “shelter in place” Tuesday to limit the spread of the new coronavirus. Although public health officials acknowledged the orders were drastic, they also agreed they were necessary.

As Coronavirus Testing Gears Up, Specialized Swabs Running Out

Nationwide, testing for coronavirus is ramping up. But the supply of specialty swabs needed to collect potential coronavirus specimens can’t keep up with demand, creating a bottleneck in testing capabilities. So two top manufacturers are working with U.S. and Italian governments to increase production.